NCT00035009已完成3 期
A Double-Blind, Multicenter, Placebo- and Active-Controlled Acute and Extension Study of MK0869 in the Treatment of Patients With Major Depressive Disorder With Melancholic Features
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 468
- 主要终点
- Change from baseline in HAMD-17 total score at week 8. Mk-0869 will be generally well tolerated
研究概览
简要总结
A clinical study to determine the efficacy and safety of MK0869 in the treatment of depression
详细描述
The duration of treatment is 8 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Change from baseline in HAMD-17 total score at week 8. Mk-0869 will be generally well tolerated
次要结局
- Actual CGI-I score at week 8, improving social disability by change from baseline in Sheehan Disability Score at Week 8, change from baseline in the HAMA score at week 8, change from baseline in depressed mood of the HAMD-17 at week 8
研究者
相似试验
已完成
3 期
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)Major Depressive DisorderNCT00048607Merck Sharp & Dohme LLC600
已完成
3 期
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073)Major Depressive DisorderNCT00042029Merck Sharp & Dohme LLC324
已完成
3 期
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063)Major Depressive DisorderNCT00034944Merck Sharp & Dohme LLC495
已完成
3 期
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD)Depressive Disorder, MajorNCT02709655H. Lundbeck A/S683
终止
2 期
Efficacy and Safety of Lu AA39959 in Patients With Bipolar DepressionBipolar DisorderNCT00771134H. Lundbeck A/S105